Predictive and Prognostic Markers in Colorectal Cancer
Explore this paper's citation graph
Summary
This article focuses on prognostic and predictive markers in CRC that have a substantial body of data in support of their potential role in routine clinical practice.
- Type
- review
- Published
- 2011-03-05
- Cited by
- 73
- References
- 90
- OpenAlex
- https://openalex.org/W1964212603
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11035265
Keywords
Medicine, Colorectal cancer, Precision medicine, Predictive marker, Epigenetics
References
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
- Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.
- Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management
- Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
- Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
- Colorectal carcinogenesis: road maps to cancer.
- Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus.
- PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.
- Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.
- Oncogenic Mutations of PIK3CA in Human Cancers
- Recurrent KRAS Codon 146 Mutations in Human Colorectal Cancer
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
- Untangling the ErbB signalling network
- 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems.
- NRAS Mutations Are Rare in Colorectal Cancer
- Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
- The Raf/MEK/ERK pathway: new concepts of activation
- Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
- The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside
- The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
Cited by
- KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis
- Mutationsanalyse und Charakterisierung von transkriptionellen Targetgenen des Metastasierungs-induzierenden Gens MACC1
- Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases
- Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB
- Histopathological and genetic aspects of colorectal cancer
- Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients
- The Effect of Aspirin on Survival in Patients with Mutated-PIK3CA Colorectal Cancers
- The Expression and Prognostic Significance of Retinoic Acid Metabolising Enzymes in Colorectal Cancer
- Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review
- Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin
- Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse
- Analysis of colorectal cancer morphology in relation to sex, age, location, and family history
- RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
- Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α
- FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma
- Promoter CpG island methylation markers in colorectal cancer: the road ahead.
- Challenges in the management of stage II colon cancer
- The clinical use of genetic analyses in colorectal cancer
- Mast Cells as a Potential Prognostic Marker in Prostate Cancer
- Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas
Related papers
- The future of precision medicine: towards a more predictive personalized medicine.
- Genomic medicine on the frontier of precision medicine
- Detecting Personalized Determinants During Drug Treatment from Omics Big Data.
- TRANSFORMING HEALTHCARE WITH PRECISION MEDICINE: UNVEILING THE FUTURE OF PERSONALIZED TREATMENT
- Critical Care and Personalized or Precision Medicine: Who needs whom?
- Precision Medicine: Tailoring Treatment to the Individual's Genomic Profile
- Prediction and Recommendation of Precision Medicine for Cancer using Machine Learning Techniques
- Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment